The term "EXPB14" does not appear in major antibody databases, including:
SAbDab (Structural Antibody Database), which catalogs all experimentally resolved antibody structures
Clinical trial registries (e.g., ClinicalTrials.gov)
Therapeutic antibody approvals (e.g., Antibody Society’s product data )
This suggests one of the following:
EXPB14 may be a proprietary or experimental antibody not yet published in open-access repositories.
The nomenclature could refer to a hypothetical or mislabeled target (e.g., conflated with expansin proteins like EXPB1 in plants).
If "EXPB14" relates to expansin proteins (common in plant cell wall modification), its antibody might target:
| Property | Hypothetical EXPB14 Antibody |
|---|---|
| Target | Expansin-B14 (plant cell wall protein) |
| Applications | Agricultural research, plant biology |
| Species Reactivity | Likely plant-specific (e.g., Oryza sativa) |
| Validation Methods | Western blot, ELISA, immunohistochemistry |
To investigate EXPB14 Antibody:
Consult Specialized Databases
UniProtKB: Search for "EXPB14" as a protein identifier.
NCBI Protein Database: Verify sequence homology or functional annotations.
Contact Commercial Antibody Providers
Explore Patent Filings
Check the USPTO or WIPO databases for proprietary antibody designs.
The absence of EXPB14 Antibody in indexed sources (e.g., PubMed, PMC , Britannica ) indicates it is either:
A newly discovered antibody awaiting publication.
A non-standard term requiring disambiguation.
KEGG: osa:4330212
EXPB14 belongs to the beta-expansin subfamily involved in plant cell wall modifications during growth and development processes in rice. The protein plays a crucial role in cell wall loosening, extension, and stress responses. Studying EXPB14 provides insights into fundamental plant growth mechanisms and potential applications in crop improvement. Antibodies against EXPB14 enable researchers to detect, localize, and quantify this protein in various experimental contexts, particularly when validated for techniques such as ELISA and Western blotting .
Comprehensive antibody validation is essential for ensuring experimental reliability. For EXPB14 antibody, implement multiple validation approaches:
Western blot analysis using recombinant EXPB14 protein as a positive control
Immunoprecipitation followed by mass spectrometry to confirm target identity
Testing in EXPB14 knockout/knockdown plant tissues as negative controls
Cross-reactivity testing against other expansin family members
Validation across multiple experimental techniques (ELISA, WB, IHC)
This multi-method approach helps disentangle different binding modes, especially critical when antibodies must discriminate between chemically similar ligands like different expansin family members . Document all validation procedures thoroughly to ensure reproducibility.
Effective sample preparation is crucial for reliable EXPB14 detection:
Flash-freeze tissue samples in liquid nitrogen and grind to a fine powder
Extract proteins using buffers containing appropriate detergents (such as RIPA buffer with protease inhibitors)
For cell wall-associated proteins like expansins, consider specialized extraction buffers that can solubilize cell wall-bound proteins
Optimize protein extraction conditions based on tissue type (roots, leaves, stems)
For immunohistochemistry, implement proper fixation protocols (typically 4% paraformaldehyde)
The specific extraction methods will need optimization depending on the target tissue and developmental stage, as EXPB14 expression varies across different plant tissues and growth conditions.
Antibody titration is essential for obtaining optimal results with minimal background. Based on established antibody validation principles:
For Western blotting: Begin with a 1:1000 dilution and test a range (1:500 to 1:5000)
For immunohistochemistry: Start with a 1:100 dilution and test a range (1:50 to 1:500)
For ELISA: Begin with a 1:500 dilution and optimize through a titration series
The optimal dilution provides the strongest specific signal with minimal background. Performance criteria of antibody reagents are application-dependent and should be validated accordingly . Document the optimal conditions for each experimental system to ensure reproducibility.
Include the following controls to ensure reliable and interpretable results:
Positive control: Recombinant EXPB14 protein or extracts from tissues known to highly express EXPB14
Negative control: Samples from EXPB14 knockout plants or tissues known not to express EXPB14
Loading control: Antibody against a constitutively expressed protein (e.g., actin, GAPDH)
Secondary antibody-only control: To assess non-specific binding
Pre-immune serum control: If available, to establish baseline reactivity
Peptide competition assay: Pre-incubate antibody with the immunizing peptide to confirm specificity
These controls help distinguish specific EXPB14 signals from background or cross-reactivity, particularly important for antibodies that must discriminate between similar epitopes .
For successful immunolocalization of EXPB14:
Tissue fixation: Use 4% paraformaldehyde in PBS for 24 hours at 4°C
Tissue processing: Dehydrate through an ethanol series and embed in paraffin or prepare for cryosectioning
Sectioning: Cut 5-10 μm sections and mount on positively charged slides
Antigen retrieval: Use citrate buffer (pH 6.0) with heat-induced epitope retrieval
Blocking: Block with 3-5% BSA or normal serum from the secondary antibody species
Primary antibody incubation: Apply optimized dilution of EXPB14 antibody and incubate overnight at 4°C
Secondary antibody application: Use fluorescently labeled or HRP-conjugated secondary antibodies
Counterstaining: DAPI for nuclei visualization if using fluorescent detection
Controls: Include sections without primary antibody and tissues from EXPB14 knockout plants if available
Specific signal validation follows similar principles to those used for other antibody applications like ErbB4/Her4 visualization in human tissues .
Differentiating between similar expansin proteins requires careful experimental design:
Sequence analysis: Compare epitope regions of EXPB14 with other expansins to predict potential cross-reactivity
Validation using recombinant proteins: Test the antibody against recombinant versions of different expansin family members
Knockout/knockdown controls: Use genetic lines where EXPB14 is silenced or knocked out
Mass spectrometry validation: Perform immunoprecipitation followed by mass spectrometry
Computational modeling: Apply biophysics-informed modeling to understand different binding modes
Drawing from advances in antibody specificity research, computational approaches can identify different binding modes associated with particular ligands, enabling discrimination between chemically similar epitopes .
Several challenges may arise when working with EXPB14 antibody:
Cross-reactivity with other expansins: Due to sequence homology, carefully validate specificity
Variable expression levels: EXPB14 expression changes with developmental stages and stress conditions
Cell wall localization challenges: As a cell wall protein, extraction and detection may require specialized protocols
Fixation artifacts: Inappropriate fixation can destroy epitopes or create false-positive signals
Batch-to-batch variation: Different antibody lots may have varying specificities and titers
To mitigate these issues:
Always validate new antibody batches before use
Include appropriate controls in each experiment
Optimize extraction protocols specifically for cell wall proteins
Document detailed experimental conditions to ensure reproducibility
Consider using multiple antibodies targeting different epitopes of EXPB14 for confirmation
Investigating EXPB14 protein interactions requires specialized approaches:
Co-immunoprecipitation (Co-IP): Use EXPB14 antibody to pull down protein complexes, then identify interacting partners
Proximity ligation assay (PLA): Detect in situ protein interactions between EXPB14 and potential partners
Bimolecular fluorescence complementation (BiFC): For in vivo visualization of protein interactions
Pull-down assays: Use purified recombinant EXPB14 as bait to identify interacting proteins
Cross-linking experiments: Chemically cross-link protein complexes before immunoprecipitation
Consider the cellular localization of EXPB14 in the cell wall and the challenges in solubilizing and maintaining protein interactions during extraction. These approaches can be informed by similar techniques used to investigate binding properties in other antibody systems .
For rigorous quantification and analysis:
Capture digital images under non-saturating conditions
Perform densitometry analysis using software like ImageJ with appropriate background correction
Normalize EXPB14 signal to loading controls (e.g., actin, GAPDH)
Include a concentration gradient of recombinant EXPB14 for standard curve generation
For statistical analysis:
Use at least three biological replicates
Apply appropriate statistical tests (t-test, ANOVA) depending on experimental design
Report both p-values and effect sizes
Consider using specialized software for immunoblot analysis that compensates for non-linear responses
This approach ensures both qualitative and quantitative reliability, similar to methods used for analyzing other biomarkers in research contexts .
Changes in EXPB14 localization may provide insights into plant stress responses:
Quantitative approach: Measure signal intensity across different cellular compartments
Co-localization analysis: Assess co-localization with organelle markers or other proteins
Time-course studies: Track EXPB14 localization changes over time after stimulus application
Correlation analysis: Connect localization changes with cell wall properties or growth rates
3D reconstruction: For complex tissue architecture, consider 3D imaging to fully capture localization patterns
When interpreting results, consider that localization changes might reflect new protein synthesis, redistribution, alterations in protein turnover, changes in cell wall architecture affecting antibody accessibility, or post-translational modifications affecting epitope recognition.
Leverage computational tools to enhance antibody specificity analysis:
Epitope mapping algorithms: Use tools like BepiPred or DiscoTope to predict antigenic regions
Sequence homology analysis: Compare predicted epitopes across expansin family members
Structural modeling: Use homology modeling to predict 3D structure and surface-exposed regions
Molecular dynamics simulations: Assess epitope accessibility and flexibility
Machine learning approaches: Recent advances demonstrate the ability to computationally design antibodies with customized specificity profiles
These approaches can help design more specific antibodies, predict potential cross-reactivity, interpret experimental results, and understand the molecular basis of antibody-antigen interactions. They represent a powerful combination of biophysics-informed modeling and experimental validation applicable beyond antibodies, offering tools for designing proteins with desired physical properties .
For cross-species and environmental studies:
Validate antibody cross-reactivity with EXPB14 homologs in target species
Establish baseline expression patterns under controlled conditions
Design sampling protocols that account for developmental stage, tissue type, and time of day
Implement standardized stress treatments with appropriate controls
Combine antibody-based detection with transcriptomic and physiological measurements
This approach enables comparative analysis of expansin function across species and environmental conditions, providing insights into evolutionary conservation and divergence of cell wall remodeling mechanisms in plants.
Working with field samples presents unique challenges:
Sample preservation: Optimize protocols for field sample collection and preservation that maintain protein integrity
Standardization: Develop internal standards to normalize across variable field conditions
Environmental metadata: Collect comprehensive environmental data alongside samples
Contaminant management: Implement protocols to remove soil and microbial contaminants
Reference samples: Include laboratory-grown reference samples for comparison